CEA was not included in the analysis because preoperative values were available only in six patients, as it is less used as a diagnostic biomarker in comparison with calcitonin and its relevance is mainly related to less differentiated MTC. The gene discussed is CEACAM5; the disease is medullary thyroid gland carcinoma.